Nervgen Pharma Corp. cash flow statement NGEN
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NGEN (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Vancouver
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1751912
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.